Cramer, P., Fink, A., Busch, R., Eichhorst, B., Wendtner, C., Pflug, N., . . . Fischer, K. (2013). Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group. Leukemia and lymphoma, 54(8), . https://doi.org/10.3109/10428194.2013.796050
Chicago-Zitierstil (17. Ausg.)Cramer, Paula, et al. "Second-line Therapies of Patients Initially Treated with Fludarabine and Cyclophosphamide or Fludarabine, Cyclophosphamide and Rituximab for Chronic Lymphocytic Leukemia Within the CLL8 Protocol of the German CLL Study Group." Leukemia and Lymphoma 54, no. 8 (2013). https://doi.org/10.3109/10428194.2013.796050.
MLA-Zitierstil (9. Ausg.)Cramer, Paula, et al. "Second-line Therapies of Patients Initially Treated with Fludarabine and Cyclophosphamide or Fludarabine, Cyclophosphamide and Rituximab for Chronic Lymphocytic Leukemia Within the CLL8 Protocol of the German CLL Study Group." Leukemia and Lymphoma, vol. 54, no. 8, 2013, https://doi.org/10.3109/10428194.2013.796050.